Journal Title:Current Reviews In Clinical And Experimental Pharmacology
Current Reviews in Clinical and Experimental Pharmacology is a peer-reviewed journal dedicated to the field of clinical and experimental pharmacology. This magazine aims to provide a platform for publishing review articles on drug mechanisms of action, pharmacodynamics, pharmacokinetics, drug therapy, and new drug development. It covers a wide range of topics from basic research to clinical applications, aiming to promote scientific exchange and knowledge updates in the field of pharmacology. The characteristic of a journal is its comprehensive review of the latest research findings, which is typically based on extensive literature reviews and provides in-depth analysis of specific drug categories or therapeutic fields. This form of article is highly valuable for researchers, clinical doctors, and students as it can help readers quickly grasp the current research status and future directions in a particular field.
The editorial team of the magazine is composed of experienced pharmacologists who ensure that the published articles have high academic standards and practical application value. In addition, journals may regularly invite leading figures in the field to write invited reviews to further enhance their influence in the academic community. It is an important academic resource dedicated to promoting the development of clinical and experimental pharmacology, suitable for professionals seeking in-depth understanding of the latest developments in drug research to read and reference.
《臨床和實(shí)驗(yàn)藥理學(xué)最新評論》是一本專注于臨床和實(shí)驗(yàn)藥理學(xué)領(lǐng)域的同行評審期刊。該雜志旨在提供一個平臺,用于發(fā)表關(guān)于藥物作用機(jī)制、藥效學(xué)、藥代動力學(xué)、藥物治療以及新藥物開發(fā)的綜述文章。它覆蓋了從基礎(chǔ)研究到臨床應(yīng)用的廣泛主題,旨在促進(jìn)藥理學(xué)領(lǐng)域的科學(xué)交流和知識更新。期刊的特點(diǎn)在于其對最新研究成果的綜合評述,這些評述通?;趶V泛的文獻(xiàn)回顧,并提供了對特定藥物類別或治療領(lǐng)域的深入分析。這種形式的文章對于研究人員、臨床醫(yī)生和學(xué)生來說是非常有價值的,因?yàn)樗鼈兡軌驇椭x者迅速把握某一領(lǐng)域的研究現(xiàn)狀和未來方向。
雜志的編輯團(tuán)隊(duì)由經(jīng)驗(yàn)豐富的藥理學(xué)家組成,他們確保發(fā)表的文章具有高學(xué)術(shù)標(biāo)準(zhǔn)和實(shí)際應(yīng)用價值。此外,期刊可能還會定期邀請領(lǐng)域內(nèi)的領(lǐng)軍人物撰寫特邀綜述,以進(jìn)一步提升其在學(xué)術(shù)界的影響力。它是一個致力于推動臨床和實(shí)驗(yàn)藥理學(xué)領(lǐng)域發(fā)展的重要學(xué)術(shù)資源,適合那些尋求深入了解藥物研究最新進(jìn)展的專業(yè)人士閱讀和參考。
Current Reviews In Clinical And Experimental Pharmacology由Bentham出版商出版,收稿方向涵蓋PHARMACOLOGY & PHARMACY全領(lǐng)域,平均審稿速度 ,影響因子指數(shù)1.3,該期刊近期沒有被列入國際期刊預(yù)警名單,廣大學(xué)者值得一試。
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:PHARMACOLOGY & PHARMACY | ESCI | Q4 | 283 / 354 |
20.2% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:PHARMACOLOGY & PHARMACY | ESCI | Q4 | 267 / 354 |
24.72% |
名詞解釋:
WOS即Web of Science,是全球獲取學(xué)術(shù)信息的重要數(shù)據(jù)庫,Web of Science包括自然科學(xué)、社會科學(xué)、藝術(shù)與人文領(lǐng)域的信息,來自全世界近9,000種最負(fù)盛名的高影響力研究期刊及12,000多種學(xué)術(shù)會議多學(xué)科內(nèi)容。給期刊分區(qū)時會按照某一個學(xué)科領(lǐng)域劃分,根據(jù)這一學(xué)科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區(qū)中,最后的劃分結(jié)果分別是Q1,Q2,Q3,Q4,Q1代表質(zhì)量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||
4.8 | 0.44 | 0.647 |
|
名詞解釋:
CiteScore:衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)。
SJR:SCImago 期刊等級衡量經(jīng)過加權(quán)后的期刊受引用次數(shù)。引用次數(shù)的加權(quán)值由施引期刊的學(xué)科領(lǐng)域和聲望 (SJR) 決定。
SNIP:每篇文章中來源出版物的標(biāo)準(zhǔn)化影響將實(shí)際受引用情況對照期刊所屬學(xué)科領(lǐng)域中預(yù)期的受引用情況進(jìn)行衡量。
是否OA開放訪問: | h-index: | 年文章數(shù): |
未開放 | -- | 22 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
4.55% | 1.3 | |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預(yù)警名單(試行)》名單: |
13.64% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶需要出版服務(wù),請聯(lián)系出版商。